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Abstract
The endoplasmic reticulum (ER) is responsible for protein folding,
modification, and trafficking. Accumulation of unfolded or mis-
folded proteins represents the condition of ER stress and triggers
the unfolded protein response (UPR), a key mechanism linking
supply of excess nutrients to insulin resistance and type 2 diabetes
in obesity. The ER harbors proteins that participate in protein fold-
ing including protein disulfide isomerases (PDIs). Changes in PDI
activity are associated with protein misfolding and ER stress. Here,
we show that thioredoxin-interacting protein (Txnip), a member
of the arrestin protein superfamily and one of the most strongly
induced proteins in diabetic patients, regulates PDI activity and
UPR signaling. We found that Txnip binds to PDIs and increases
their enzymatic activity. Genetic deletion of Txnip in cells and
mice led to increased protein ubiquitination and splicing of the
UPR regulated transcription factor X-box-binding protein 1 (Xbp1s)
at baseline as well as under ER stress. Our results reveal Txnip as
a novel direct regulator of PDI activity and a feedback mechanism
of UPR signaling to decrease ER stress.
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Introduction
The endoplasmic reticulum (ER) is an organelle that participates in
metabolic pathophysiologies including insulin resistance and type 2
diabetes (Hotamisligil, 2010). The ER is responsible for folding,
modification, and trafficking of a large number of secreted and
membrane proteins, and it is part of a very dynamic system capable
of quickly adapting to changes in metabolic and synthetic cellular
demand. To maintain its functional integrity, the ER has to
constantly balance the capacity of its protein chaperones with the
load of unfolded proteins that are newly synthesized by the cell.
A mismatch between the load of unfolded proteins and the capacity
of protein chaperones in the ER results in the accumulation of
unfolded or misfolded proteins in the ER; this condition has been
termed ‘ER stress’ (Hotamisligil, 2010). Upon ER stress, three differ-
ent response pathways are activated that are collectively called the
‘unfolded protein response’ (UPR). This short-term adaptive system
is necessary to maintain balance in the protein folding machinery by
activating protein modification and gene expression programs
designed to inhibit protein translation, increase the production of
protein chaperones, and stimulate protein degradation. However,
chronic UPR activation by ER stress can be detrimental and may
lead to maladaptive changes in cellular signaling that ultimately
contribute to disease processes including insulin resistance and type
2 diabetes (Hotamisligil, 2010; Samuel & Shulman, 2012).
Protein disulfide isomerases (PDIs) are oxidoreductases that
are responsible for the introduction of disulfide bonds into
proteins through thiol-disulfide exchange reactions. A common
feature of most PDIs is that they contain at least one thioredoxin-
like fold with a CXXC redox active motif (Hatahet & Ruddock,
2009). A study that investigated the consequences of S-nitrosyla-
tion on PDI function showed that changes in PDI activity lead to
increased protein misfolding and ER stress and contribute to
neurodegeneration, a central feature of Parkinson’s and Alzhei-
mer’s disease (Uehara et al, 2006). This provides proof of princi-
ple that regulation of PDI activity is relevant for ER stress-related
disease progression.
Thioredoxin-interacting protein (Txnip) is a protein that binds
directly to thioredoxin and regulates redox signaling in the cell
(Nishiyama et al, 1999). Accumulating evidence demonstrates that
Txnip, like other members of a protein family sometimes called the
‘alpha arrestins’, serves as a multifunctional adaptor protein for differ-
ent signaling pathways (Lee et al, 2013). In addition to regulating
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types; we and others have shown that Txnip deficiency decreases
gluconeogenesis and increases lipogenesis, adipogenesis, and insu-
lin sensitivity in vitro and in vivo (Donnelly et al, 2004; Yamawaki
et al, 2005; Chen et al, 2008; Chutkow et al, 2008, 2010; Yoshioka
et al, 2012). The molecular mechanisms responsible for the Txnip-
null metabolic phenotype are not yet clearly defined. Of note, Txnip
is one of the most dramatically upregulated genes in response to
glucose in humans, suggesting a prominent role of Txnip in either
adaptive or maladaptive changes of metabolism in response to
glucose (Parikh et al, 2007).
Here, we report a new role of Txnip as a regulator of ER stress.
We identified PDIs as a potentially critical mechanistic link between
Txnip and UPR signaling. We show that Txnip binds to PDIs and
increases PDI activity. Txnip deficiency leads to increased protein
ubiquitination and UPR signaling, indicating that it might serve as a
feedback regulator for diabetes-induced ER stress.
Results
Txnip interacts with PDIA6
Given the structural similarities between PDIs and thioredoxin, we
hypothesized that Txnip interacts with PDIs and regulates their
enzymatic activity. We established a pulldown assay that revealed
a direct protein-protein interaction between Txnip and PDIA6
(Fig 1A). We have previously shown that Txnip interacts with
thioredoxin covalently through a disulfide exchange reaction that
requires the Txnip cysteine residue at position 247 (Patwari et al,
2006). We therefore tested whether this cysteine residue is also
essential for interaction with PDIA6 using a C247S Txnip mutant.
The C247S mutation abrogated Txnip’s interaction with PDIA6
(Fig 1A). Next, we tested whether Txnip interacts with the redox
active sites of PDIA6. PDIA6 contains two thioredoxin folds, each
with a CGHC redox active motif (Hatahet & Ruddock, 2009). Pull-
down analyses using full-length PDIA6 (1-421), the N-terminal
domain (1-118), and the C-terminal domain (135-421) of PDIA6
showed that Txnip interacts with both the N- and the C-terminal
thioredoxin folds of PDIA6 (Fig 1B). The N-terminal cysteine resi-
due of CXXC redox active motifs is necessary for the initiation of
disulfide exchange reactions through bimolecular nucleophilic
substitution reactions (Lee et al, 2013). The reaction starts with
the formation of a mixed disulfide bond following a nucleophilic
attack of the N-terminal cysteine on the disulfide bond of the
substrate protein. Subsequently, the intermediate mixed disulfide
bond is targeted by a nucleophilic attack of the C-terminal cyste-
ine, thereby completing the final disulfide exchange reaction (Lee
et al, 2013). In order to test the hypothesis that the CGHC redox
active motifs of PDIA6 are the sites of interaction with Txnip, we
mutated cysteines in PDIA6 at positions 36 and 171 to serines, the
N-terminal cysteine residues of the PDIA6 thioredoxin-fold CGHC
motifs. Neither the C36S mutant nor the C171S mutants of PDIA6
bound to Txnip (Fig 1C and D). Mutation of the C-terminal resolv-
ing cysteine residue of CXXC motifs does not lead to abrogation of
interaction, but rather in potential trapping of the substrate, more
pronounced with cysteine to alanine mutations than with cysteine
to serine mutation (Lee et al, 2013). We therefore mutated the
C-terminal cysteine residue of PDIA6 at position 174 to alanine
and serine; as expected, the cysteine to alanine and serine mutants
were still able to interact with Txnip (Fig 1D). These results show
that PDIs with a CXXC redox motif bind to Txnip requiring the
PDI redox active site, suggesting the possibility that Txnip can
regulate PDI activity.
Txnip is the only alpha arrestin interacting with PDIs
To test the specificity of the Txnip-PDI interaction, we tested the
interactions of PDI, PDIA3, PDIA4, PDIA13, and PDIA15 with Txnip.
Txnip bound to all of these CGHC-containing PDIs, but not with
PDIA8 and PDIA9, which are PDIs that do not contain a CXXC redox
active motif (Fig 2A). To further confirm these findings, we
performed reverse pulldown analyses, which confirmed the interac-
tion between PDIs and Txnip (Fig 2B). Txnip is one of six members
of the arrestin domain-containing proteins sometimes called the
alpha arrestins (Lee et al, 2013); since Txnip is the only arrestin
domain-containing protein that interacts with thioredoxin, we tested
whether other alpha arrestins bind to PDIA6. These experiments
showed that Txnip is the only alpha arrestin that bound to PDIA6
(Fig 2C). Thus, Txnip interacts with a number CGHC-containing
PDIs, a specific feature of Txnip not shared by other members of the
alpha arrestin protein family.
A B
C D
Figure 1. Txnip interacts with PDIA6.
HEK293TN cells were transfected with the indicated plasmids, and Western blot
analyses with the indicated antibodies of input lysates and pulldown eluates
after affinity chromatography of Txnip were performed.
A Pulldown of PDIA6 with Txnip but not with Txnip C247S mutant.
B Pulldown of full-length PDIA6 (1-421), N-terminal (1-118), and C-terminal
(135-421) domain of PDIA6 with Txnip.
C Pulldown of wild-type N-terminal (1-118) domain of PDIA6, but not of N-
terminal C36S mutant domain of PDIA6 with Txnip.
D Pulldown of wild-type C-terminal (135-421) domain of PDIA6, but not of C-
terminal C171S mutant of PDIA6, with Txnip. C174S and C174A mutations
do not abrogate interaction with Txnip.
Source data are available online for this figure.
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Since PDIs are predominantly located in the ER (Hatahet & Ruddock,
2009), we investigated whether Txnip is also located in this cellular
compartment. Previous studies have shown that addition of an arti-
ficial N-glycosylation site leads to partial (GT1.4) or subtotal
(GT1.4tail) glycosylation of proteins that are localized in the luminal
site of the ER (Kaup et al, 2011). We generated Txnip-GT1.4 and
Txnip-GT1.4tail mutant constructs and performed Western blot
analyses showing glycosylation of Txinp (Fig 3A), indicating that
Txnip is located in the ER at some point of its life cycle. An impor-
tant potential limitation of our pulldown assay is the use of PDI
constructs with an N-terminal HA-tag which could interfere with
intracellular trafficking. Therefore, we performed immunofluores-
cence analyses to confirm that HA-tagged PDI is still located in the
ER (Supplementary Fig S1A and B). To test the hypothesis that
Txnip interacts with PDIs in physiologic conditions, we first
performed pulldown analyses in HEK293TN cells that were trans-
fected with Txnip only, showing that Txnip interacts with endoge-
nous PDIA6 (Fig 3B). To confirm these findings, we chose an
unbiased proteomics approach to identify protein-protein interaction
partners for Txnip (Gao et al, 2009). Affinity chromatography with
subsequent SDS–PAGE and mass spectrometry analyses confirmed
that Txnip interacts with several endogenously expressed PDIs
(Table 1, Supplementary Fig S2 and see Supplementary Dataset S1).
To assess the relative abundance of free Txnip versus Txnip that is
in complex with PDI, we trapped Txnip-PDI complexes using a free
sulfhydryl alkylation method (Chutkow & Lee, 2011). All free
cysteine residues were blocked with N-ethylmaleimide (NEM);
non-reducing SDS–PAGE and subsequent Western blot analyses
showed that a small but significant amount of Txnip is complexed
with PDI (Supplementary Fig S3A and B). Taken together, these
results show that Txnip interacts with endogenous PDIA6.
Txnip increases PDI activity
Since PDIs function primarily as oxidants, introducing disulfide
bonds into folding proteins, their reduction potential is higher than
that of denatured proteins (Hatahet & Ruddock, 2009). We therefore
hypothesized that Txnip shifts the PDI redox equilibrium to the
reduced state, thereby increasing its capacity to reduce other
proteins. We measured PDI activity in the protein extracts from cells
overexpressing PDI with and without Txnip using a coupled insulin
reduction assay. In this assay, reduction of insulin catalyzed by PDI
is coupled to the oxidation of NADPH + H
+, which is quantified by
the decrease in absorbance at 340 nm. As expected, Txnip increased
PDI activity in this assay (Fig 4A). To confirm these findings, we
performed an additional PDI activity assay; the insulin turbidity
AB C
Figure 2. Txnip is the only alpha arrestin that interacts with PDIs.
HEK293TN cells were transfected with the indicated plasmids, and Western blot analyses with the indicated antibodies of input lysates and pulldown eluates after affinity
chromatography were performed.
A Pulldown of PDI, PDIA3, PDIA4, PDIA13, PDIA15, but not of PDIA8 and PDIA8 with Txnip.
B Pulldown of Txnip with PDI, PDIA4, PDIA6, PDIA13, and PDIA15.
C Pulldown of PDIA6 with Txnip but not with other arrestin domain-containing proteins Arrdc1-4.
Source data are available online for this figure.
AB
Figure 3. Txnip is located in the ER and interacts with endogenous
PDIA6.
A Western blot analysis of Txnip and Txnip mutants with an N-glycosylation
site (Txnip GT1.4, and Txnip GT1.4tail) transfected into HEK293TN cells.
B HEK293TN cells were transfected with Txnip or Txnip C247S mutant
plasmids. Pulldown of endogenous PDIA6 with Txnip but not with Txnip
C247S mutant.
Source data are available online for this figure.
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734assay is based on the aggregation of the B chain of insulin at
increasing concentrations following reduction of insulin catalyzed
by PDI, which is quantified by an increase in absorbance at 650 nm.
The results of this experiment confirmed our previous finding,
showing that Txnip increases PDI activity (Fig 4B). Taken together,
these results reveal Txnip as a novel regulator of PDI function.
Accumulation of misfolded or unfolded proteins that are poten-
tially toxic poses a threat to cellular integrity. The increase in
protein misfolding that is associated with decreases in PDI activity
induces ER stress, which triggers the UPR and defenses against ER
stress (Uehara et al, 2006; Hotamisligil, 2010). A recent study
confirmed that Xbp1s induces PDI expression as part of ER stress-
related regulation of lipid homeostasis (Wang et al, 2012). There-
fore, we performed immunofluorescence analyses of mouse embry-
onic fibroblasts (MEFs) from WT and Txnip-KO mice. Both at
baseline and under tunicamycin-induced ER stress conditions,
Txnip-KO MEFs had higher levels of PDI expression (Supplementary
Fig S4A and B). This indicates that reduced PDI activity and
increased ER stress could activate the UPR in Txnip-KO cells, ulti-
mately leading to a compensatory increase in PDI levels.
Txnip deficiency increases protein ubiquitination
Another adaptive cellular mechanism to ER stress is targeting
misfolded or unfolded proteins for proteasomal degradation, a
process known as endoplasmic reticulum-associated degradation
(ERAD) (Guerriero & Brodsky, 2012). A key step in this process is
substrate ubiquitination that targets ER proteins for retrotransloca-
tion to the cytosol and subsequent proteasomal degradation (Nakats-
ukasa et al, 2008). We hypothesized that changes in PDI chaperone
and enzymatic activity could lead to the accumulation of unfolded
and ubiquitinated proteins (Uehara et al, 2006). We analyzed the
accumulation of ubiquitinated proteins in WT and Txnip-KO MEFs
with and without subjecting them to ER stress through tunicamycin
(Fig 5A, negative controls in Supplementary Fig S4C). Both at base-
line and under stimulated conditions, the number of ubiquitin-
positive accumulations of proteins markedly increased in a
dose-dependent manner in the Txnip-KO cells, consistent with an
increase in proteins targeted for degradation (Fig 5B). These findings
suggest the possibility of increased UPR signaling in Txnip-KO cells.
Txnip regulates ER stress
The best-studied and most conserved branch of the UPR is medi-
ated through the inositol-requiring enzyme 1a (IRE1a) pathway
(Hetz et al, 2011). IRE1a is a transmembrane kinase and endonu-
clease that directly binds to unfolded proteins, which leads to
lateral oligomerization, autophosphorylation, and activation of its
ribonuclease domain (Sidrauski & Walter, 1997; Gardner & Walter,
2011). This domain cleaves 26 nucleotides out of the mRNA
encoding for X-box binding protein 1 (Xbp1), which leads to a
translational frame shift and the generation of the active transcrip-
tion factor Xbp1s (Sidrauski & Walter, 1997). This non-conven-
tional splicing event is UPR specific, and there are no other Xbp1
activation pathways known to date (Hotamisligil, 2010; Hetz et al,
2011). Xbp1s initiates a transcriptional program that upregulates a
broad spectrum of proteins involved in maintaining ER homeosta-
sis. We investigated the effects of Txnip deficiency on Xbp1s levels
by treating MEFs from WT and Txnip-KO mice with tunicamycin.
There was a dramatic increase in Xbp1s transcript levels in Txnip-
KO cells compared to WT both at baseline and under stimulated
conditions in a dose-dependent manner (Fig 6A). This was also
true for L-azetidine carboxylic acid and thapsigargin, two other ER
stress-inducing reagents with mechanisms different from tunicamy-
cin (Supplementary Fig S5A and B). Since PDI and PDIA6 expres-
sion is induced via the UPR pathway (Hatahet & Ruddock, 2009),
we also studied the effect of Txnip deficiency on Pdi and Pdia6
Table 1. Mass spectrometry results for Txnip protein-protein
interactions
Protein
MW
(kDa)
Control
(hits)
Txnip
(hits)
Txnip 44 – 2302 Validation
Txn 12 – 388
Txn21 8 – 16
Pdia47 3 – 72 Protein disulfide
isomerases Pdia64 8 – 25
Pdia15 44 – 3
AB
Figure 4. Txnip increases PDI activity.
HEK293TN cells were transfected with the indicated plasmids, and lysates were used to perform enzymatic activity assays.
A PDI activity was measured using a coupled insulin reduction assay (n = 3).
B PDI activity was measured using an insulin aggregation assay (n = 4).
© 2014 Brigham and Women's Hospital EMBO Molecular Medicine Vol 6 |N o6 | 2014
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735transcript levels in MEFs. Both at baseline and under ER stress,
Pdi and Pdia6 transcript levels were significantly increased
(Supplementary Fig S5C–E). Next, we investigated the reversibility
of this effect in WT and Txnip-KO MEFs treated with tunicamycin
by co-treatment with 4-phenylbutyric acid (PBA) and tauroursode-
oxycholic acid (TUDCA). PBA and TUDCA are chemical chaper-
ones that stabilize protein conformation, improve ER folding
capacity, and facilitate trafficking of mutant proteins; as such, they
have been shown to reduce ER stress levels (Ozcan et al, 2006).
Co-treatment of tunicamycin-treated WT and Txnip-KO MEFs with
PBA and TUDCA led to an almost complete normalization of
Xbp1s transcript levels (Fig 6B). These results indicate that Txnip
deficiency leads to a pronounced increase in splicing of Xbp1,
revealing Txnip’s role in controlling the UPR.
To investigate the effect of increased Txnip expression on Xbp1s
levels, we subjected 3T3-L1 fibroblasts stably overexpressing Txnip
to tunicamycin. There was a significant reduction in Xpb1s both at
baseline and under stimulation in Txnip-overexpressing cells
compared to WT (Fig 6C). To further study the role of PDI in this
phenotype, we stably transduced Txnip-overexpressing 3T3-L1 cells
with shRNA, knocking down PDI about 80% (PDI shRNA 3) and
more than 95% (PDI shRNA 4, Txnip, and PDI expression levels of
these cell lines in Supplementary Fig S6A and B). In addition, we
treated Txnip-overexpressing cells with 16F16, a specific PDI inhibi-
tor (Hoffstrom et al, 2010). While Txnip overexpression decreased
Xbp1s transcript levels, this effect was reversed by knockdown of
PDI in a transcript dose-dependent manner; pharmacologic inhibi-
tion of PDI had the same effect (Fig 6D). These data show that
increased levels of Txnip significantly reduce Xbp1s transcript
levels.
To confirm these findings at the protein level, we also performed
Western blot analyses of Xbp1. Treatment of WT and Txnip-KO
MEFs with tunicamycin led to an increase in Xbp1 expression in a
dose-dependent manner at each time point in Txnip-KO MEFs
compared to WT cells (Fig 6E). Co-treatment of these cells with the
chemical chaperones PBA and TUDCA led to a reduction in Xbp1
protein levels compared to treatment with tunicamycin alone
(Fig 6F). Txnip overexpression in 3T3-L1 fibroblasts led to a reduc-
tion in Xbp1 protein levels, both at baseline and under tunicamycin-
stimulated conditions (Fig 6G).
To test whether Txnip also regulates UPR signaling in vivo,w e
extracted RNA from the livers of WT and Txnip-KO mice and
measured transcript levels of UPR signaling molecules, including
Xbp1s and its target genes Erdj3, Serp1, and Edem1. There was a
robust increase in Xbp1s transcript levels as well as downstream
targets of Xbp1s in vivo (Fig 7A–D). These changes in gene expres-
sion levels translated into increased protein levels of Xbp1 in the
liver samples of Txnip-KO mice (Fig 7E). Next, we investigated
whether these changes in ER stress signaling would also be revers-
ible by the treatment with TUDCA and PBA in vivo. We generated
liver-specific Txnip-KO mice and confirmed increased Xbp1 tran-
script levels compared to WT (Fig 7F). This increase was reversed
by the treatment with chemical chaperones (Fig 7F). Taken
together, these results reveal that Txnip is a regulator of Xbp1s
levels and UPR signaling in vivo.
Discussion
Beta and visual arrestins are well known as important regulators of
G-protein-coupled receptor signaling. Canonically, they bind to
active phosphorylated receptors and cause desensitization by
mediating their ubiquitination and endosomal recycling (Lohse
et al, 1990). More recently, the role of beta arrestins has expanded,
as beta arrestins are now recognized to initiate their own signaling
cascades independent of G-proteins as part of multifunctional signal-
AB
Figure 5. Txnip deficiency increases protein ubiquitination.
Mouse embryonic fibroblasts from wild-type (WT) and Txnip-null (KO) mice were treated with vehicle or tunicamycin (1 lg/ml) for 6 h. Cells were subsequently fixed,
permeabilized, and stained for indicated proteins.
A Levels of Txnip and mono- and polyubiquitinated protein accumulations visualized by immunofluorescence under epifluorescence microscopy. Scale bar, 25 lm.
B Quantification of intracellular ubiquitin accumulations per field, normalized to cell number (n = 5 fields). *P = 0.04954, ***P = 0.00097 versus WT.
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Figure 6. Txnip regulates Xbp1s in vitro.
A Relative transcript levels of Xbp1s measured by qPCR normalized to 18S in mouse embryonic fibroblasts (MEFs) from wild-type (WT) and Txnip-null (KO) mice
treated with increasing concentrations of tunicamycin for 2 h( n = 4). 0 lg/ml: ***P = 0.00004 versus WT; 0.5 lg/ml: ***P = 0.00001 versus WT; 1 lg/ml:
***P = 0.0005 versus WT.
B Same as in (A) in WT and KO MEFs treated with tunicamycin and chemical chaperones PBA (20 mM) and TUDCA (5 mg/ml) for 6 h( n = 4). TU/PBA/TUDCA  / / :
***P = 0.00008 versus WT; TU/PBA/TUDCA +/ / :* * P = 0.004 versus WT; TU/PBA/TUDCA +/+/ : ***P = 0.0002 versus WT; TU/PBA/TUDCA +/ /+:
***P = 0.0000003 versus WT.
C Same as in (A) in empty vector-transduced (EV) and Txnip-overexpressing (OE) 3T3-L1 fibroblasts treated with tunicamycin for 2 h( n = 4). 0 lg/ml: **P = 0.001
versus EV; 1 lg/ml: ***P = 0.00007 versus EV.
D Same as in (A) in EV and OE 3T3-L1 fibroblasts transduced with non-targeting (N/T) shRNA, PDI shRNA, or treated with PDI inhibitor 16F16 (5 lM) for 8 h( n = 4).+/
 / / :* P = 0.01 versus EV;  /+/ / : ***P = 0.00008 versus N/T shRNA;  / /+/ :* * P = 0.002 versus N/T shRNA;  / / /+: *P = 0.016 versus N/T shRNA.
E-G Protein levels of Xbp1 and actin measured by Western blot analyses in: (E) WT and KO MEFs at increasing durations of treatment with tunicamycin (1 lg/ml), (F)
WT and KO MEFs after treatment with tunicamycin (1 lg/ml for 2 h) and chemical chaperones PBA (20 mM) and TUDCA (5 mg/ml), and (G) EV and Txnip 3T3-L1
fibroblasts with and without tunicamycin treatment (1 lg/ml for 2 h).
Source data are available online for this figure.
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737ing scaffolds (Rajagopal et al, 2010). Phylogenetic studies have
shown that beta arrestins are members of a larger arrestin superfam-
ily with predicted structural similarities, including the two arrestin
folds that identify arrestins in general (Alvarez, 2008). The proteins
sometimes called alpha arrestins are phylogenetically more ancient
than beta arrestins and include Txnip and arrestin domain-contain-
ing protein 1-5 (Arrdc1-5). Accumulating evidence suggests that
alpha arrestins, similar to the extensively studied beta arrestins,
participate in a variety of signaling pathways, establishing arrestin
domain-containing proteins as integrators of signaling pathways
(Patwari et al, 2009, 2011; Nabhan et al, 2012). For example, we
have recently shown that Arrdc3 regulates obesity and energy
expenditure in adipose tissue through interaction with b-adrenergic
receptors in humans and mice (Patwari et al, 2011).
As part of the alpha arrestin family, Txnip also shares the arres-
tin-like sequence homology with other arrestin domain-containing
proteins, and indeed, it inhibits cellular glucose uptake independent
of its ability to bind to thioredoxin (Patwari et al, 2009). However,
here we report that Txnip’s unique capability among the alpha
arrestins to interact with thioredoxin-like proteins, such as PDIs,
allows it to participate in both redox-dependent and redox-indepen-
dent metabolic signaling pathways. We show that Txnip interacts
with PDIs and increases PDI activity. As a consequence, we identi-
fied Txnip as a novel regulator of ER stress and UPR signaling
including Xbp1s.
Recent reports showed that Txnip itself is induced by ER stress,
serving as a link between ER stress and inflammatory signaling
(Lerner et al, 2012; Oslowski et al, 2012). Activation of IRE1a leads
to the reduction in the Txnip mRNA destabilizing microRNA-17
(Lerner et al, 2012). This results in increased levels of both Txnip
mRNA and Txnip protein upon stimulation with different ER
stress-inducing agents. Txnip subsequently activates the NLRP3
inflammasome, which results in increased interleukin 1b secretion
(Zhou et al, 2010). These studies indicate that Txnip is an ER
stress-sensitive gene that is involved in linking UPR signaling with
inflammatory activation. While increased ER stress levels induce
Txnip expression, our results show that increased Txnip levels
ultimately lead to decreased Xbp1s levels, the downstream signal-
ing molecule of IRE1a. Taken together, these data reveal a negative
feedback mechanism by which increased IRE1a activation leads to
the induction of Txnip, which subsequently results in increased
PDI activity and downregulation of IRE1a signaling. Since Txnip is
one of the most strongly upregulated genes in diabetes (Parikh
et al, 2007), this reveals Txnip as a key negative feedback regula-
tory mechanism of the UPR to decrease Xbp1s levels via direct
regulation of PDI.
Being under post-transcriptional regulation by the IRE1a path-
way and affecting its downstream signaling molecule Xbp1s
suggests that Txnip is involved in downstream signaling of this
pathway as well. Several studies have shown that Xbp1s decreases
gluconeogenesis and increases lipogenesis, adipogenesis, and
insulin sensitivity (Ozcan et al, 2004; Lee et al, 2008; Sha et al,
2009; Zhou et al, 2011). Interestingly, Txnip deficiency in mice is
associated with decreased gluconeogenesis, increased lipogenesis,
A BCD
EF
Figure 7. Txnip regulates Xbp1s in vivo.
A-D Relative transcript levels of Xbp1s, Erdj3, Serp1, and Edem1 measured by qPCR normalized to 18S from liver samples from wild-type (WT) and Txnip-null (KO) mice
(n = 5), [*P = 0.04 versus WT in (A); *P = 0.02 versus WT in (B); *P = 0.04 versus WT in (C), *P = 0.03 versus WT in (D)].
E Protein levels of Xbp1 and actin measured by Western blot analyses in liver samples of WT and KO mice.
F Relative transcript levels of Xbp1s in liver samples of liver-specific Txnip-KO mice (Cre
+) and littermate controls (Cre
 ) treated with vehicle, tauroursodeoxycholic
acid (TUDCA), or 4-phenylbutyric acid (PBA) for 21 days (n = 3–4). *P = 0.019,* * P = 0.005 versus Cre
+ (vehicle only); ***P = 0.001 versus Cre
  (vehicle only).
Source data are available online for this figure.
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bolic phenotype (Donnelly et al, 2004; Chutkow et al, 2008, 2010).
The present study therefore provides evidence that some of the
metabolic phenotypes of Txnip deficiency may be attributable to its
regulation of UPR signaling.
It is somewhat surprising that Txnip, which has been character-
ized as an inhibitor of thioredoxin activity, increases activity of the
thioredoxin fold-containing PDI. However, PDI primarily functions
as an oxidase and has a higher standard reduction potential
(Er
00
=  180 mV) than denatured proteins (Er
00 =  220 mV), while
thioredoxin that functions as a reductase has a lower standard
reduction potential (Er
00 =  270 mV) (Krause et al, 1991; Lund-
strom & Holmgren, 1993; Hatahet & Ruddock, 2009). We therefore
hypothesized that Txnip, being oxidized by PDI, shifts the PDI
redox equilibrium to the reduced state, thereby increasing its
capacity to reduce other proteins, which was confirmed in our in
vitro PDI activity assays. Subjecting cells to ER stress increases PDI
expression levels (Hatahet & Ruddock, 2009); but given the
complex nature of the UPR, it is not surprising that overall PDI
activity decreased after subjecting cells to ER stress using tunica-
mycin (Supplementary Fig S7). These findings highlight a limita-
tion of the present study, which is the use of crude cell extracts for
PDI activity assays, which also contain additional proteins like
thioredoxin reductase and thioredoxin as well as glutaredoxins,
which could interfere in the assay. Ideally, purified proteins should
be used in enzymatic assays. However, despite efforts by multiple
laboratories including our own to purify Txnip protein (Supplemen-
tary Figs S8 and S9), only crystallization of the N-terminal domain
of human Txnip has been published so far (Polekhina et al, 2011).
We have previously shown that results from enzymatic assays
using crude cell extracts correlate well with in vitro assays using
purified proteins (Holmgren & Bjornstedt, 1995; Patwari et al,
2006).
In conclusion, we report Txnip as a new regulator of ER stress
through a direct interaction with PDIs. Txnip deficiency results in
increased protein ubiquitination and increased Xbp1s signaling in
vitro and in vivo, indicating that Txnip might serve as a feedback
regulator for diabetes-induced ER stress.
Materials and Methods
Reagents
All reagents for biochemical and molecular biology assays were
obtained from Sigma-Aldrich unless indicated otherwise. All
reagents for cell culture experiments were obtained from Invitrogen
unless indicated otherwise. Anti-Txnip antibody for Western blot
analysis was from MBL International (JY2), anti-VDUP1 antibody
for immunofluorescence was from Invitrogen, anti-PDIA6 antibody
was from Abnova (3B4), anti-FLAG antibody was from Sigma-
Aldrich (M2), anti-HA antibody was from Covance (16B12), anti-
PDI antibody was from Novus Biologicals (RL77), anti-ubiquitin
antibody was from Enzo Life Sciences (FK2), anti-Xbp1 antibody
was from Santa Cruz, and anti-actin antibody was from Sigma-
Aldrich. 4-Phenylbutyric acid and tauroursodeoxycholic acid were
obtained from EMD Chemicals.
Plasmid construction
Lentiviral vectors for transient transfection and stable transduction
were used as described previously (Patwari et al, 2011; Yoshioka
et al, 2012). Briefly, Txnip, Txnip C247S, and ARRDC1-4 were
subcloned into pCDH-CMV-MCS-EF1-Green-T2A-Puro (System
Biosciences) with an N-terminal tandem Strep/FLAG epitope tag
(mDYKDDDDKgsaasWSHPQFEKgggsgggsgggsWSHPQFEK) (Gloeck-
ner et al, 2009). PDI, PDIA3, PDIA4, PDIA6, PDIA6 (1-118), PDIA6
(1-118) C36S, PDIA6 (135-421), PDIA6 (135-421) C171S, PDIA6
(135-421) C174S, PDIA6 (135-421) C174A, PDIA8, PDIA9, PDIA13,
and PDIA15 were subcloned into pCDH-CMV-MCS-EF1-Green-T2A-
Puro (System Biosciences) with an HA epitope tag at the N-terminus
of the signal sequence (YPYDVPDYA). cDNAs for ARRDC1,
ARRDC2, PDI, PDIA3, PDIA4, PDIA8, PDIA9, and PDIA13 were
subcloned from commercially available plasmids (Open Biosys-
tems). PDIA6 (1-118), PDIA6 (1-118) C36S, and PDIA6 (135-421)
constructs were kind gifts from Dr Roland K. Strong (Fred Hutchin-
son Cancer Research Center, Seattle, WA). PDIA6 (135-421) C171S,
PDIA6 (135-421) C174S, and PDIA6 (135-421) C174A mutations
were made using ‘Round the Horn’ site-directed mutagenesis as
described previously (Chutkow & Lee, 2011). Txnip-GT1.4 and
Txnip-GT1.4tail mutants were generated through the addition of C-
terminal artificial N-glycosylation sites (GT1.4: LEAAAAAANATV,
GT1.4tail: LEAAAAAANATVAAASGDVWDI), as described previ-
ously (Kaup et al, 2011) and subsequent subcloning into pCDH-
CMV-MCS-EF1-Green-T2A-Puro (System Biosciences). PDI shRNA
constructs were made using the following oligonucleotides (TRC
shRNA Library):
mPdi shRNA #1 F: 50-CCGGGCATTTCATCTGTGAGGCATTCTC-
GAGAATGCCTCACAGATGAAATGCTTTTTG-30, mPdi shRNA #1 R:
50-AATTCAAAAAGCATTTCATCTGTGAGGCATTCTCGAGAATGCCT
CACAGATGAAATGC-30, mPdi shRNA #2 F: 50-CCGGGCAGAGGC-
TATTGATGACATACTCGAGTATGTCATCAATAGCCTCTGCTTTTTG
-30, mPdi shRNA #2 R: 50-AATTCAAAAAGCAGAGGCTATTGATGA-
CATACTCGAGTATGTCATCAATAGCCTCTGC-30, mPdi shRNA #3 F:
50-CCGGCCCAAGAGTGTATCTGACTATCTCGAGATAGTCAGATACA
CTCTTGGGTTTTTG-30, mPdi shRNA #3 R: 50-AATTCAAAAACC-
CAAGAGTGTATCTGACTATCTCGAGATAGTCAGATACACTCTTGG
G-30, mPdi shRNA #4 F: 50-CCGGGCTCTGAGATTCGACTAG-
CAACTCGAGTTGCTAGTCGAATCTCAGAGCTTTTTG-30,m P d is h R N A
#4 R: 50-AATTCAAAAAGCTCTGAGATTCGACTAGCAACTCGAGTTG
CTAGTCGAATCTCAGAGC-30, mPdi shRNA #5 F: 50-CCGGCAGCG-
CATACTTGAGTTCTTTCTCGAGAAAGAACTCAAGTATGCGCTGTTT
TTG-30, mPdi shRNA #5 R: 50-AATTCAAAAACAGCGCATACTT-
GAGTTCTTTCTCGAGAAAGAACTCAAGTATGCGCTG-30, N/T shRN
AF :5 0-CCGGCAACAAGATGAAGAGCACCAACTCGAGTTGGTGCTC
TTCATCTTGTTGTTTTTG-30, N/T shRNA R: 50-AATTCAAAAACAA-
CAAGATGAAGAGCACCAACTCGAGTTGGTGCTCTTCATCTTGTTG-30.
Oligos were inserted into a pLKO.1 neo vector (Addgene #13425
contributed by Sheila Stewart) and stably transduced into the indi-
cated cell lines as described previously (Patwari et al, 2006).
Pulldown assay
Pulldown assays were performed as previously described (Yoshioka
et al, 2012). Briefly, indicated plasmids were transfected into
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Biosciences). Cells were lysed in 0.5% Triton X-100, 150 mM NaCl,
50 mM Tris, 1 mM phenylmethanesulfonyl fluoride, and protease
inhibitors, pH 7.8. Txnip pulldown assay was performed by affinity
chromatography using magnetic Streptactin beads (IBA) according to
the manufacturer’s instructions using a wash buffer containing 0.5%
Triton X-100, 500 mM NaCl, 50 mM Tris, pH 7.8. Input lysates and
pulldown eluates were analyzed by SDS–PAGE and immunoblots.
Proteomics screen for Txnip protein-protein interactions
Txnip was subcloned into pCDH-CMV-MCS-EF1-Puro (System
Biosciences) with an N-terminal tandem Strep/FLAG epitope tag
(mDYKDDDDKgsaasWSHPQFEKgggsgggsgggsWSHPQFEK) (Gloeckner
et al, 2009). HEK293F cells were stably transduced with Txnip or an
empty vector control and clonally selected; cell culture was scaled
up in suspension cell culture (Integra). Affinity chromatography
was performed using Streptactin resin columns (IBA) according to
the manufacturer’s instructions. Eluates were subjected to SDS–
PAGE and mass spectrometry analysis as described previously (Gao
et al, 2009; Yoshioka et al, 2012).
Coupled insulin reduction assay
PDI activity was assayed as described previously (Lambert & Freedman,
1983). In this assay, PDI uses reduced glutathione (GSH) as an elec-
tron donor for the reduction of insulin. This reaction is then coupled
to a second redox reaction in which glutathione reductase catalyzes
the reduction of oxidized glutathione (GSSG) using NADPH + H
+ as
an electron donor. HEK293TN cells were transfected with the indi-
cated plasmids; cell lysates were added to a reaction mix with the
final concentrations of 30 lM insulin, 8 mM GSH, 1 U/ml glutathi-
one reductase, and 120 lM NADPH in a buffer containing 100 mM
K3PO4, 1 mM EDTA, pH 7.0. The oxidation of NADPH + H
+ to
NADP
+ was monitored by the decrease in absorbance at 340 nm.
Insulin turbidity assay
The assay was performed as described previously (Holmgren,
1979). In this assay, PDI breaks the two disulfide bonds between the
insulin A and B chains, resulting in the precipitation of B chain. This
precipitation can be monitored by an increase in absorbance at
650 nm. HEK293TN cells were transfected with the indicated plas-
mids; cell lysates and recombinant PDI were added to a reaction
mix with the final concentrations of 30 lM insulin, 20 lg recombi-
nant PDI, and 1 mM DTT, in a buffer containing 84 mM sodium
phosphate, 2.67 mM sodium EDTA, pH 7.0. Precipitation of insulin
was measured by an increase in absorbance at 650 nm.
Immunofluorescence
Cells were plated on chambered coverglass (Thermo Scientific)
coated with 1 lg/ml fibronectin. After fixation in 4% paraformalde-
hyde (Electron Microscopy Sciences), cells were permeabilized in
ice-cold methanol at  20°C and blocked in 5% goat serum (Vector
Laboratories). After incubation with the indicated primary antibod-
ies and respective species-matched AlexaFluor-conjugated second-
ary antibodies (Invitrogen), and Hoechst, cells were imaged using a
Zeiss LSM 710 confocal, a Zeiss LSM 510 confocal, and a standard
epifluorescence microscope. Ubiquitin-positive accumulations were
quantified with ImageJ (NIH, Bethesda, MD) using a standardized
threshold and normalized to cell count.
Gene expression analysis
Gene expression analysis was performed as described previously
(Chutkow et al, 2010). Briefly, RNA extraction from cells and
tissues was performed using Trizol reagent (Invitrogen) according
to the manufacturer’s instructions. cDNA was obtained from 2 lgo f
total RNA using the TaqMan Reverse Transcription kit (Applied
Biosystems). Quantitative real-time PCRs were performed in a 7300
Real-time PCR system (Applied Biosystems). Relative amounts of
mRNA were normalized to 18S. Primer sequences were from the
MGH Primer Bank (Spandidos et al, 2010) or described previously
(Oslowski & Urano, 2011): Xpb1s F: 50-CTGAGTCCGAATCAGGTG-
CAG-30, Xbp1s R: 50-GTCCATGGGAAGATGTTCTGG-30, Erdj3 F: 50-
GTACCTCATCGGGACTGTGAT-30, Erdj3 R: 50-CAGAACCTCATAAG-
CAGCACC30, Serp1 F: 50-GCAACGTCGCTAAGACCTC-30, Serp1 R:
50-CATGCCCATCCTGATACTTTGAA-30, Edem1 F: 50-CTACCTGC-
GAAGAGGCCG-30, Edem1 R: 50-CTACCTGCGAAGAGGCCG-30, Pdi
F: 50-GCCGCAAAACTGAAGGCAG-30, Pdi R: 50-GGTAGCCACGGAC
ACCATAC-30, Pdia6 F: 50-AGCTGCACCTTCTTTCTAGCA-30, Pdia6
R: 50-CAGGCCGTCACTCTGAATAAC-30.
Animals
Generation of transgenic Txnip
fl/fl mice containing a loxP-flanked
exon 1 locus was described previously (Yoshioka et al, 2007). Total
Txnip-KO mice were obtained by crossing Txnip
fl/fl mice with Prot-
amine-Cre transgenic mice resulting in heterozygous total Txnip-KO
mice. Intercrossing of heterozygous mice resulted in homozygous
Txnip-KO mice; only mice without the Cre transgene were used for
further breeding (Yoshioka et al, 2007, 2012; Chutkow et al, 2008,
2010). The following primers were used for Txnip-KO genotyping as
described previously: F1: 50-TTT CGT TTG GGT TTT CAA GC-30, F2:
50-CTT CAC CCC CCT AGA GTG AT-30,R 2 :5 0-CCC AGA GCA CTT
TCT TGG AC-30 (Yoshioka et al, 2007). Liver-specific Txnip-KO mice
were obtained by crossing Txnip
fl/fl mice with Albumin-Cre trans-
genic mice (Chutkow et al, 2008). The following primers were used
for Cre genotyping as described previously: F: 50-GCG GTC TGG CAG
TAA AAA CTA TC-30,R :5 0-GTG AAA CAG CAT TGC TGT CAC TT-30
(Chutkow et al, 2008). Mice were housed under controlled tempera-
ture and lighting with free access to water and food. Mice were main-
tained and experiments with mice were performed in accordance with
the Institutional Animal Care and Use Committees of Harvard Medical
School. All animal experiments were approved by the Institutional
Animal Care and Use Committees of Harvard Medical School. In vivo
studies were performed as described previously with minor modifica-
tions (Ozcan et al, 2006). Male 8- to 12-week-old mice received
intraperitoneal injections of 250 mg/kg TUDCA twice a day (9 AM
and 9 PM, 500 mg/kg/day) for 21 days. Control animals
received intraperitoneal injections of vehicle at the same time points
for the same period of time. PBA was given in the drinking water at a
concentration of 20 mM for 21 days (Zode et al, 2011). Control
animals were given vehicle in the drinking water for the same period
of time.
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740For more detailed methods see the Supplementary Materials and
Methods.
Statistics
All data are presented as mean   SEM with the number (n) of inde-
pendent experiments underlying each data point. Differences
between the groups were tested by unpaired two-tailed Student’s
t-test. Differences between multiple groups were tested by one-way
ANOVA followed by post hoc analysis with the Tukey–Kramer test.
A P-value <0.05 was considered statistically significant.
Supplementary information for this article is available online:
http://embomolmed.embopress.org
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